3 April 2019

Postponed: Targeted medicine: new solutions from biotechnology

Organised by:

SCI's Biotechnology Group and Fine Chemicals Group

Cambridge, UK

Registration opens 1/7/2019

Registration Closed

This event is no longer available for registration.


Biotechnology started with the DNA sequencing breakthroughs, the human genome project and cloning/designing cellular organisms. Now, in the light of ever more ground-breaking technology, the SCI Biotechnology Interest Group provides a forum for this industry sector. Its first major event will bring together advances in precision medicine - a concept that seeks to discover/design drugs that deliver a more individual approach to disease management.

Biotechnology is providing new solutions in this area and speakers from both academia and industry will cover the major themes of advances in biopharmaceuticals, AI, gene editing, protein design and drug development - from the molecular level of proteins and DNA through genomes and cells to disease models and therapeutic interventions.

The meeting will also provide networking opportunities for all those with an interest in bringing together biosciences and technology in this important initiative.

This event will be of interest to those working in SME's, the pharmaceutical industry and universities who are interested in the possibilities of precision medicine led by advances in biotechnology.
09.00 Registration and refreshments
09.30 Opening remarks
09.35 The impact of AI on drug discovery
Dr Georgia McGaughey, Vertex
10.15 Phenotypic screening in iPSC-derived neurons - a new paradigm in drug discovery
Dr Sandra Lubitz, Evotec
10.45 Refreshment break
11.15 ANN based methods for discovery of biomarkers, phenotypic drivers and drug targets - a cancer case study
Prof Graham Ball, Nottingham Trent University
11.45 Precise genome editing: Applying CRISPR in drug discovery
David Fisher, AstraZeneca
12.15 Developing bicycle toxin conjugates to target cancerous tumours'
Gemma Mudd, Bicycle Therapeutics
12.45 Lunch and exhibition
13.45 Strategies to target protein-protein interactions
Marta Westwood, UCB
14.15 Inhalation dosing - targeted delivery of respiratory therapeutics
Andrew Carr, Charles River
14.45 Biologics Plenary: Delivering innovation in Biotechnology: Experiences and learning from the last 15 years
Graham Hillier, CPI
15.25 Refreshment break
15.55 Development of engineered biocatalysts for the synthesis of pharmaceuticals
Prof Nick Turner, University of Manchester
16.25 Industrial application of imine reductases for biocatalytic reductive amination
Dr Markus Schober, GSK
16.55 Networking Discussion
17.30 Networking and refreshments

Venue and Contact

Downing College

Regent Street

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org


Early bird fees before Friday 1 March 2019

£100   SCI Member/ ONE Nucleus member/ OBN Member 
£40   SCI Student Member
£70   Subsidised Members
£140   Non-Member

Standard fees after Friday 1 March 2019

£120   SCI Member/ ONE Nucleus member/ OBN Member
£50   SCI Student Member
£80   Subsidised Members
£160   Non-Member

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations

Booking Process/Deadlines
For booking terms and conditions click here.
CPD Info

SCI Members attending this meeting are able to claim CPD points.

 CPD Accredition Logo

Additional Info

Call for Poster Abstracts

Anyone wishing to present a poster should submit a one-page abstract to conferences@soci.org by Friday 15 March 2019 with "Targeted medicine: new solutions from biotechnology - poster abstract" in the subject line. Selected poster presenters will be given the opportunity to give a flash presentation.

Exhibition and Sponsorship

An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.

Become an SCI Member to receive benefits and discounts

Join SCI